HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Schwaiger, M. Search for Related Content PubMed PubMed Citation Articles by Schwaiger, M.

Myocardial Perfusion Imaging with PET

Nuklearmedizinische Klinik und Poliklinik, Der Technischen Universität München, Klinikum Rechts der Isar, Munich, Germany

Correspondence: For correspondence or reprints contact: Prof. Dr. Markus Schwaiger, Nuklearmedizinische Klinik und Poliknik, Der Technischen Universität München, Klinikum Rechts der Isar, Ismaninger Strasse 22, 8000 München 80, Germany.

ABSTRACT

Although SPECT has become an accepted imaging technique for myocardial perfusion studies, there are several advantages to evaluating coronary artery disease (CAD) with PET. CAD is a complex, dynamic disease and quantitative measurements of myocardial blood flow by PET can improve the functional characterization of CAD. The major advantage of PET over SPECT is its ability to provide attenuation-corrected images, which decreases incidence of attenuation artifacts and increases specificity. Myocardial perfusion imaging with PET can also provide more accurate information on localization of disease, as well as quantitative assessment, in absolute values, of myocardial blood flow. The measurement of regional flow reserve allows for physiologic characterization of stenosis severity, and may provide early detection of CAD as well as prognostic information. The disadvantage of PET, compared to SPECT, is that the equipment and operations are more expensive. As more accurate diagnostic and prognostic data lead to improved patient management, the cost-to-benefit ratios of PET and SPECT in the clinical setting need to be further analyzed to determine which diagnostic test is most efficient in the work-up of patients with suspected or known CAD.

Key Words: myocardial perfusion imaging • coronary artery disease • SPECT • PET

FOOTNOTES

This paper was presented in part at the Annual Meeting of the Society of Nuclear Medicine on June 8, 1993 as part of a Continuing Medical Education Seminar organized by the Cardiovascular Council.

This article has been cited by other articles:

				E. Inglese, L. Leva, R. Matheoud, G. Sacchetti, C. Secco, M. Brambilla, P. Gandolfo, and G. Sambuceti Reply: High Intraindividual Variability of Global Myocardial 18F-FDG Uptake over Time J. Nucl. Med., September 1, 2008; 49(9): 1570 - 1571. [Full Text] [PDF]

				E. Nagel, C. Klein, I. Paetsch, S. Hettwer, B. Schnackenburg, K. Wegscheider, and E. Fleck Magnetic Resonance Perfusion Measurements for the Noninvasive Detection of Coronary Artery Disease Circulation, July 29, 2003; 108(4): 432 - 437. [Abstract] [Full Text] [PDF]

				N. Al-Saadi, E. Nagel, M. Gross, A. Bornstedt, B. Schnackenburg, C. Klein, W. Klimek, H. Oswald, and E. Fleck Noninvasive Detection of Myocardial Ischemia From Perfusion Reserve Based on Cardiovascular Magnetic Resonance Circulation, March 28, 2000; 101(12): 1379 - 1383. [Abstract] [Full Text] [PDF]

				H. Jadvar, H. W. Strauss, and G. M. Segall SPECT and PET in the Evaluation of Coronary Artery Disease RadioGraphics, July 1, 1999; 19(4): 915 - 926. [Abstract] [Full Text] [PDF]

				A. M. Garber and N. A. Solomon Cost-Effectiveness of Alternative Test Strategies for the Diagnosis of Coronary Artery Disease Ann Intern Med, May 4, 1999; 130(9): 719 - 728. [Abstract] [Full Text] [PDF]